Lamotrigine as add-on therapy in treatment-resistant epilepsy

Journal of International Medical Research

Volumn 27, Issue 3, 1999, Pages 148-157

  Pimentel, J ^a   Guimaraes M L ^b   Lima, L ^c   Leitao O ^d   Sampaio, M J ^e  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^d HOSPITAL EGAS MONIZ   (Portugal)

^e CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Add on therapy; Lamotrigine; Treatment resistant epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HEMATURIA; HUMAN; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NYSTAGMUS; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PORTUGAL; SELF REPORT; SOMNOLENCE; TREMOR; VERTIGO; VESTIBULAR DISORDER; VOMITING;

EID: 0344172819     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059902700306     Document Type: Article

References (24)

1. Messenheimer J, Ramsay RE, Willmore LJ, et ai: Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, crossover trial. Epilepsia 1994; 35: 113-121.
2. Loiseau P, Yuen AWC, Duché B, et al: A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res 1990; 7:136-145.
3. Schapel GJ, Beran RG, Vajda FJE, et al. Double-blind, placebo controlled crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 1993; 56: 448-453.
4. Matsuo F, Bergen D, Faught E, et al: Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993; 43: 2284-2291.
5. Jawad S, Richens A, Goodwin G, et al: Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989; 30: 356-363.
6. Binnie CD, Debets RMC, Engelsman M, et al: Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989; 4: 222-229.
7. Betts T: Communication of pooled results of 27 open studies of lamotrigine (Lamictal) as add-on therapy for up to 12 months in adults with treatment resistant epilepsy (abstract). J Neurol 1990; 237 (Suppl 1): S52.
8. Mataringa MI: The efficacy of Lamictal (lamotrigine) as add-on therapy in children whose seizures were not satisfactorily controlled by other antiepileptic drugs (abstract). Epilepsia 1997; 38 (Suppl 3): 31.
9. Svejdová M, Hovorka J, Sakmanová Z, et al: Lamotrigine in refractory epilepsy (abstract). Epilepsia 1997; 38 (Suppl 3): 31.
10. Arman F, Akboyhak A, Turan H, et al: Lamotrigine add-on therapy in drug resistant epilepsy (abstract). Epilepsia 1997; 38 (Suppl 3): 69.
11. Czapiñski P, Terczyñski A: Lamotrigine (Lamictal) add-on therapy in patients with refractory partial seizures: an open 12-week prospective trial (abstract). Epilepsia 1996; 37 (Suppl 4): 62.
12. Maxoutova A: Lamotrigine effects in children with resistant epilepsy (abstract). Epilepsia 1996; 37 (Suppl 4): 70.
13. Striano A, Meo R, Bilo L, et al: Lamotrigine as add-on therapy in drug resistant epilepsies. Efficacy and tolerability in the different epileptic syndromes (abstract). Epilepsia 1996; 37 (Suppl 4): 78.
14. Sander JWAS, Patsalos PN, Oxley JR, et al: A randomised double-blind placebo controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990; 6: 221-226.
15. Banks GK, Beran RG: Neuropsychological assessment in lamotrigine treated epileptic patients. Clin Exp Neurol 1991; 28: 230-237.
16. Smith D, Baker G, Davies G, et al: Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 312-322.
17. Chadwick D: Measuring antiepileptic therapies: the patient vs the physician viewpoint. Neurology 1994; 44 (Suppl 8): S24-S28.
18. Clifford JS, Yuen AWC, Brodie MJ: Open multicentre trial of lamotrigine in patients with treatment resistant epilepsy withdrawing from add-on to lamotrigine monotherapy (abstract). Epilepsia 1994; 35 (Suppl 8): S31.
19. Faught ER, Leroy RF, Messenheimer JA, et al: Clinical experience with lamotrigine (Lamictal) monotherapy for partial seizure in adult outpatients (abstract). Epilepsia 1992; 33 (Suppl 3): S82.
20. Cohen AF, Land GS, Breimer DD, et al: Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin Pharmacol Ther 1987; 42: 535-541.
21. Hubbell JP, Garnett NR, Pellock JM, et al: Pharmacokinetics of lamotrigine (BW430C) in epileptic patients. Epilepsia 1985; 26: 537.
22. International Classification of Epileptic Seizures. Epilepsia 1981; 22: 489-501.
23. Binnie CD: The efficacy of lamotrigine. Rev Contemp Pharmacother 1994; 5: 115-122.
24. Sander JWAS, Patsalos PN, Owley JR, et al: A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990; 7: 226-229.